WO2002020028A3 - Methode et composition destinees a ameliorer la vision - Google Patents

Methode et composition destinees a ameliorer la vision Download PDF

Info

Publication number
WO2002020028A3
WO2002020028A3 PCT/US2001/027487 US0127487W WO0220028A3 WO 2002020028 A3 WO2002020028 A3 WO 2002020028A3 US 0127487 W US0127487 W US 0127487W WO 0220028 A3 WO0220028 A3 WO 0220028A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
vitamin
natural mixed
enhancing vision
lutein
Prior art date
Application number
PCT/US2001/027487
Other languages
English (en)
Other versions
WO2002020028A2 (fr
Inventor
A Glenn Braswell
Inna Yegorova
Original Assignee
A Glenn Braswell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Glenn Braswell filed Critical A Glenn Braswell
Priority to AU2001288736A priority Critical patent/AU2001288736A1/en
Publication of WO2002020028A2 publication Critical patent/WO2002020028A2/fr
Publication of WO2002020028A3 publication Critical patent/WO2002020028A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La présente invention concerne des compositions et des méthodes destinées à la prévention des troubles de la vue, permettant de protéger les cellules contre les effets néfastes des radicaux libres. Cette méthode consiste à administrer à un sujet une composition renfermant de l'acide alpha-lipoique, des mélanges de tocophérols naturels, de la vitamine C, des bioflavonoïdes d'agrumes, des extraits d'écorce de pin, de la lutéine, des mélanges de caroténoïdes naturels et de la vitamine A.
PCT/US2001/027487 2000-09-06 2001-09-04 Methode et composition destinees a ameliorer la vision WO2002020028A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001288736A AU2001288736A1 (en) 2000-09-06 2001-09-04 Method and composition for enhancing vision

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65637500A 2000-09-06 2000-09-06
US09/656,375 2000-09-06

Publications (2)

Publication Number Publication Date
WO2002020028A2 WO2002020028A2 (fr) 2002-03-14
WO2002020028A3 true WO2002020028A3 (fr) 2003-02-27

Family

ID=24632753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/027487 WO2002020028A2 (fr) 2000-09-06 2001-09-04 Methode et composition destinees a ameliorer la vision

Country Status (2)

Country Link
AU (1) AU2001288736A1 (fr)
WO (1) WO2002020028A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0208081D0 (en) * 2002-04-09 2002-05-22 Boots Co Plc Skincare compositions and methods
NZ526098A (en) * 2003-05-23 2005-10-28 Enzo Nutraceuticals Ltd Use of a plant extract containing flavonoids rich in proanthocyanidins for the prevention or treatment of migraine
US7718697B2 (en) * 2003-12-17 2010-05-18 Alcon, Inc. Method for treating glaucoma comprising administering α-lipoic acid
US20070166354A1 (en) 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
US8012513B2 (en) 2006-06-08 2011-09-06 The Procter & Gamble Company Method for promoting eye health
AU2007323468A1 (en) * 2006-11-22 2008-05-29 Ocumedic Aps Compositions and methods of using same for treatment of a disease or disorder of the eye and/or the adnexa of the eye
ES2542176T3 (es) * 2008-01-18 2015-07-31 Horphag Research Ip (Mir) Ltd. Tratamiento de la presión intraocular anómala
CA2738357C (fr) * 2011-04-07 2019-08-06 Amerisciences, Lp Methodes et compositions visant a favoriser la sante ocluaire
SI2717690T1 (sl) 2011-06-13 2020-09-30 Oraldent Limited Oftalmični sestavki
WO2020227578A1 (fr) * 2019-05-07 2020-11-12 Aciont Inc. Formulations d'acide lipoïque

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033494A1 (fr) * 1997-02-04 1998-08-06 Kosbab John V Compositions et procedes destines a la prevention et au traitement de maladies degeneratives vasculaires
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033494A1 (fr) * 1997-02-04 1998-08-06 Kosbab John V Compositions et procedes destines a la prevention et au traitement de maladies degeneratives vasculaires
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals

Also Published As

Publication number Publication date
AU2001288736A1 (en) 2002-03-22
WO2002020028A2 (fr) 2002-03-14

Similar Documents

Publication Publication Date Title
EP1072254A4 (fr) Compositions alimentaires, compositions orales et compositions medicinales servant a prevenir ou traiter la parodontose et procede de prevention ou de traitement de la parodontose
ATE322904T1 (de) Zusammensetzung zum verbesserten zellenschutz welche ein lipophiles antioxydans sowie ein hydrophilen antioxidans enthält
WO2002020028A3 (fr) Methode et composition destinees a ameliorer la vision
WO2005105020A3 (fr) Procede d'elaboration de compose pour le dessin de tatouage non permanent, et procede d'utilisation du compose
WO2004078138A3 (fr) Traitement prophylactique de la neoplasie epidermique induite par les uv
WO2005091891A3 (fr) Compositions et methodes permettant de prevenir et de traiter des maladies de la peau et des cheveux
WO2005020932A3 (fr) Formulation d'un melange de flavonoides et de flavanes a cycle b utilise dans la prevention et le traitement du declin cognitif et des anomalies de la memoire dues a l'age
WO2005065669A8 (fr) Composition et methodes destinees a inhiber la progression de la degeneration maculaire et a favoriser une vision saine
WO2007038421A3 (fr) Preparations et extraits de baies
WO2000013654A3 (fr) Preparation a base de carotenoides
WO2003086329A3 (fr) Compositions et methodes de soin de la peau
WO2003059312A3 (fr) Preparations cosmetiques ou dermatologiques permettant d'empecher l'irritation cutanee par du peroxyde
WO2006032115A3 (fr) Composition contre des maladies cardio-vasculaires
JP2017039759A (ja) 皮膚用化粧料
EP1527770A3 (fr) composition cosmétique pour former une masque de beauté
WO2004080380A3 (fr) Utilisation de polyphenols catechniques pour la preparation de compositions destinees a favoriser la pigmentation naturelle de la peau
WO2007080198A8 (fr) Lentille ophtalmique therapeutique et prophylactique pour les yeux pseudo-aphaques et/ou dans un processus neurodegeneratif
EP1300084A3 (fr) Composition pour le traitement des insuffisances veineuses chroniques a l'aide d'un extrait de feuilles de vigne rouge
WO2000044344A3 (fr) Agent de soin antioxydant pour la peau
EP1443897B1 (fr) Composition a base de carotenoides et methode destinee a proteger la peau
BR0316003A (pt) Lenços e produtos absorventes contendo antioxidante
AU2002363613A1 (en) Carotenoid composition and method for protecting skin
WO2004073675A8 (fr) Composition cosmetique a effet eclaircissant, procede de production et utilisation de ladite composition
AU2003226709A1 (en) Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations
WO2003066034A3 (fr) Composes et compositions tires d'olives et methodes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO LETTER FORM 1205A HAS BEEN SENT ON 04/07/2003)

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP